Search by Title Article Topic - Any -AdvocacyCertificationClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure AwarenessHeart Failure GuidelinesHFSA Annual Scientific MeetingHFSA AwardsHFSA Board Certification ReviewHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterHFSA MembershipIn The NewsIndustryJournal of Cardiac FailureMentorshipNursingPartnersPatient ResourcePodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Feb 6 2019 | New Development in Akcea’s hATTR Compass Program Practice News Industry Read More Oct 23 2018 | Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant Practice News Industry Read More Mar 2 2018 | FDA Approves Impella Ventricular Support Systems Practice News Industry FDA has recently approved the Impella Ventricular Support Systems to be marketed. Read More Dec 1 2017 | Repatha Wins FDA Approval for Stand-Alone CVD Prevention Practice News Industry Read More Nov 16 2017 | St. Luke’s Spotlights Critical Link Between Type 2 Diabetes and Heart Disease in Partnership With Boehringer Ingelheim and Eli Lilly and Company Practice News Industry Read More Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Next page Next › Last page Last »
Oct 23 2018 | Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant Practice News Industry Read More
Mar 2 2018 | FDA Approves Impella Ventricular Support Systems Practice News Industry FDA has recently approved the Impella Ventricular Support Systems to be marketed. Read More
Dec 1 2017 | Repatha Wins FDA Approval for Stand-Alone CVD Prevention Practice News Industry Read More
Nov 16 2017 | St. Luke’s Spotlights Critical Link Between Type 2 Diabetes and Heart Disease in Partnership With Boehringer Ingelheim and Eli Lilly and Company Practice News Industry Read More
